Company name Lululemon Athletica inc.
Stock ticker LULU
Live stock price [stckqut]LULU[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $102.16
Target stock price (averages with growth) $105.05
Target stock price (averages with no growth) $51.11
Target stock price (manual assumptions) $101.59

The following company description is from Google Finance: http://www.google.com/finance?q=lulu

Lululemon Athletica Inc. is a designer, distributor and retailer of technical athletic apparel. The Company’s segments include Company-operated stores, Direct to consumer and Other. The Company offers a line of apparel and accessories for women, men and female youth. Its apparel assortment includes items, such as pants, shorts, tops and jackets designed for healthy lifestyle activities and athletic pursuits, such as yoga, running, other sweaty pursuits and athletic wear for female youth. The Company conducts its business through two channels: Company-operated stores and direct to consumer. It operates approximately 360 Company-operated stores located in the United States, Canada, Australia, New Zealand, the United Kingdom, Singapore, Hong Kong, Germany and Puerto Rico. Its direct to consumer segment includes lululemon and ivivva e-commerce Websites, www.lululemon.com and www.ivivva.com, and other country and region specific Websites.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Lululemon Athletica inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Lululemon Athletica inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $77.38
  • Growth: 0.16
  • Current EPS (TTM): $1.9
  • P/E: 41
  • Future EPS Calc: $3.99
  • Future Stock Price Calc: $163.61
  • Target stock price: $101.59

[/s2If]
I hope that this makes you a Confident Investor.

Starbucks Corp. [stckqut]SBUX[/stckqut] said Monday that it is expanding health-care benefits for all eligible part-time and full-time workers. A new online platform created with Aon PLC [stckqut]AON[/stckqut] will offer as many as six carriers and five levels of coverage. Workers could save up to $800 annually by selecting a plan that better suits their needs, Starbucks said in a statement. Starbucks staffers will also have access to Healthcare Advocates to help choose a health care plan.

The company will continue to cover about 70% of premium costs and 100% of preventive care services. Starbucks employs more than 160,000 workers and has been providing health care to eligible workers since 1988. Starbucks shares are down 0.2% in Monday trading and 4.5% for the year so far. The S&P 500 is up 6.1% for the year to date.

As the economy improves and there is more competition for workers, expect this to turn into a trend.

Source: Starbucks expands health-care benefits for all eligible part-time and full-time workers

Company name Aspen Technology, Inc.
Stock ticker AZPN
Live stock price [stckqut]AZPN[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $60.34
Target stock price (averages with growth) $57.32
Target stock price (averages with no growth) $25.79
Target stock price (manual assumptions) $50.37

The following company description is from Google Finance: http://www.google.com/finance?q=azpn

Aspen Technology, Inc. provides process optimization software solutions designed to manage and optimize plant and process design, operational performance and supply chain planning. The Company operates through two segments: subscription and software, and services. Its subscription and software segment is engaged in the licensing of process optimization software solutions and associated support services. The Company’s services segment includes professional services and training. Its aspenONE software and related services have been developed for companies in the process industries, including the energy, chemicals, and engineering and construction industries. The Company’s aspenONE software applications are organized into two suites: aspenONE Engineering, and aspenONE Manufacturing and Supply Chain. It has designed and developed its software applications across three principal business areas: Engineering, Manufacturing and Supply chain management.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Aspen Technology, Inc.

 

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Aspen Technology, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $39.09
  • Growth: 0.2
  • Current EPS (TTM): $1.63
  • P/E: 20
  • Future EPS Calc: $4.05
  • Future Stock Price Calc: $81.11
  • Target stock price: $50.36

[/s2If]
I hope that this makes you a Confident Investor.

Company name ABIOMED, Inc.
Stock ticker ABMD
Live stock price [stckqut]ABMD[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $153.31
Target stock price (averages with growth) $169.57
Target stock price (averages with no growth) $77.13
Target stock price (manual assumptions) $151.03

The following company description is from Google Finance: http://www.google.com/finance?q=abmd

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company’s products include Impella 2.5, a percutaneous micro heart pump with an integrated motor and sensors; Impella CP, which is primarily used by either interventional cardiologists to support patients in the catheter lab or by surgeons in the heart surgery suite; Impella 5.0 and Impella LD, a percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute; AB5000, a circulatory support system for the temporary support of acute heart failure patients in profound shock, and Symphony, a minimally invasive implantable cardiac assist device.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in ABIOMED, Inc..

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of ABIOMED, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $99.23
  • Growth: 0.2
  • Current EPS (TTM): $0.85
  • P/E: 115
  • Future EPS Calc: $2.11
  • Future Stock Price Calc: $243.23
  • Target stock price: $151.02

[/s2If]
I hope that this makes you a Confident Investor.

New rules aimed at stockbrokers will have enormous impacts on the way Americans save for retirement.

The rules aren’t coming from the government’s financial regulatory apparatus but from the Labor Department. The Labor Department is releasing final regulations that will require brokers getting paid to provide investment guidance on a retirement account to act solely in the best interest of the investor.

Brokers’ recommendations to this point have only had to be “suitable”—a less rigorous standard that critics say has encouraged some advisers to charge excessive fees, favor investments that offer hidden commissions and recommend securities that can be difficult for investors to sell.

The shift, more than six years in the making, could cut the total costs of investing by billions of dollars annually. But it also will put the federal government deeper into the business of deciding what Americans should do with their own money.

Investors who now pay commissions when they buy stocks or bonds will likely be moved into accounts where brokers collect up to 1% of their assets every year—a change that will compensate brokers for increasing the size of the account, not selling products. A range of popular but controversial offerings like variable annuities, commodity pools and some real estate investment trusts will likely be de-emphasized for retirement accounts. In their place investors increasingly will be offered low-cost index funds that passively mimic market returns. Moving funds from a 401(k) into an individual retirement account could become cheaper, as brokers comply with requirements that the fees are reasonable and the investment strategy is appropriate. And investors who feel they were wronged will find it easier to sue for breach of contract.

The flip side of those changes is that the money-management industry faces its most sweeping overhaul in a generation. Small firms could be heavily pressured by compliance costs, while some large financial firms could be left better off than before.

Mountains of money hang in the balance. Total assets held in IRAs stood at $7.3 trillion at the end of 2015, an amount roughly equal to the combined gross domestic product of Germany and Japan. An additional $6.7 trillion sits in 401(k)s and similar employer-sponsored retirement plans, estimates the Investment Company Institute, a trade group for fund managers.

Changes aimed at how that money is managed could easily spread into the broader market for financial advice.

This will have a sweeping impact. The Labor Department’s new rules on retirement-account advice will touch large numbers of American savers and financial companies.

New rules will affect:

  • 21 million retirement plans and IRAs
  • 2,800 financial firms

To comply financial institutions will have to produce about 86 million written disclosures and notices in the first year with an estimated cost of $69 million

 

Source: Saving for Retirement? The Rulebook Is About to Change – WSJ